Cucurbitacin B inhibits human breast cancer cell proliferation through disruption of microtubule polymerization and nucleophosmin/B23 translocation

BMC Complementary and Alternative Medicine

Volumn 12, Issue , 2012, Pages

  Duangmano, Suwit ^a,c,d   Sae lim, Phorntip ^b   Suksamrarn, Apichart ^b   Domann, Frederick E ^c   Patmasiriwat, Pimpicha ^d  

^a WALAILAK UNIVERSITY   (Thailand)

^b RAMKHAMHAENG UNIVERSITY   (Thailand)

^c UNIVERSITY OF IOWA   (United States)

^d MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Breast cancer; Cucurbitacin B; Nucleophosmin B23; Tubulin

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; CUCURBITACIN; CUCURBITACIN B; MYC PROTEIN; NUCLEOPHOSMIN; PROTEOME; TUBULIN; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER GROWTH; CELL CYCLE; CELL CYCLE DISTRIBUTION; CELL GROWTH; CONTROLLED STUDY; DRUG INHIBITION; DRUG STRUCTURE; FLOW CYTOMETRY; G2 PHASE CELL CYCLE CHECKPOINT; GENE EXPRESSION; GENE TRANSLOCATION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOFLUORESCENCE TEST; M PHASE CELL CYCLE CHECKPOINT; MICROTUBULE ASSEMBLY; MORPHOLOGY; ONCOGENE C MYC; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN POLYMERIZATION; REAL TIME POLYMERASE CHAIN REACTION; TUBULIN POLYMERIZATION ASSAY KIT; VALIDATION PROCESS; WESTERN BLOTTING;

EID: 84867308614     PISSN: None     EISSN: 14726882     Source Type: Journal    
DOI: 10.1186/1472-6882-12-185     Document Type: Article

References (42)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010, 127:2893-2917. 10.1002/ijc.25516, 21351269.
2. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011, 61:69-90. 10.3322/caac.20107, 21296855.
3. Desantis C, Siegel R, Bandi P, Jemal A. Breast cancer statistics, 2011. CA Cancer J Clin 2011, 61:409-418.
4. Mavrogenis AF, Pala E, Romantini M, Guerra G, Romagnoli C, Maccauro G, Ruggieri P. Side effects of radiation in musculoskeletal oncology: clinical evaluation of radiation-induced fractures. Int J Immunopathol Pharmacol 2011, 24:29-37.
5. Mavrogenis AF, Papagelopoulos PJ, Romantini M, Angelini A, Ruggieri P. Side effects of chemotherapy in musculoskeletal oncology. J Long Term Eff Med Implants 2010, 20:1-12. 10.1615/JLongTermEffMedImplants.v20.i1.10, 21284582.
6. Jayaprakasam B, Seeram NP, Nair MG. Anticancer and antiinflammatory activities of cucurbitacins from Cucurbita andreana. Cancer Lett 2003, 189:11-16. 10.1016/S0304-3835(02)00497-4, 12445672.
7. Tannin-Spitz T, Grossman S, Dovrat S, Gottlieb HE, Bergman M. Growth inhibitory activity of cucurbitacin glucosides isolated from Citrullus colocynthis on human breast cancer cells. Biochem Pharmacol 2007, 73:56-67. 10.1016/j.bcp.2006.09.012, 17049494.
8. Che CT, Fang XD, Phoebe CH, Kinghorn AD, Farnsworth NR, Yellin B, Hecht SM. High-field 1H-NMR spectral analysis of some cucurbitacins. J Nat Prod 1985, 48:429-434. 10.1021/np50039a010, 3839841.
9. Zhang Y, Ouyang D, Xu L, Ji Y, Zha Q, Cai J, He X. Cucurbitacin B induces rapid depletion of the G-actin pool through reactive oxygen species-dependent actin aggregation in melanoma cells. Acta Biochim Biophys Sin (Shanghai) 2011, 43:556-567.
10. Chan KT, Li K, Liu SL, Chu KH, Toh M, Xie WD. Cucurbitacin B inhibits STAT3 and the Raf/MEK/ERK pathway in leukemia cell line K562. Cancer Lett 2010, 289:46-52. 10.1016/j.canlet.2009.07.015, 19700240.
11. Chan KT, Meng FY, Li Q, Ho CY, Lam TS, To Y, Lee WH, Li M, Chu KH, Toh M. Cucurbitacin B induces apoptosis and S phase cell cycle arrest in BEL-7402 human hepatocellular carcinoma cells and is effective via oral administration. Cancer Lett 2010, 294:118-124. 10.1016/j.canlet.2010.01.029, 20153103.
12. Yin D, Wakimoto N, Xing H, Lu D, Huynh T, Wang X, Black KL, Koeffler HP. Cucurbitacin B markedly inhibits growth and rapidly affects the cytoskeleton in glioblastoma multiforme. Int J Cancer 2008, 123:1364-1375. 10.1002/ijc.23648, 18561312.
13. Wakimoto N, Yin D, O'Kelly J, Haritunians T, Karlan B, Said J, Xing H, Koeffler HP. Cucurbitacin B has a potent antiproliferative effect on breast cancer cells in vitro and in vivo. Cancer Sci 2008, 99:1793-1797. 10.1111/j.1349-7006.2008.00899.x, 18627377.
14. Jordan MA, Wilson L. Microtubules and actin filaments: dynamic targets for cancer chemotherapy. Curr Opin Cell Biol 1998, 10:123-130. 10.1016/S0955-0674(98)80095-1, 9484604.
15. Jordan MA, Wilson L. Microtubules as a target for anticancer drugs. Nat Rev Cancer 2004, 4:253-265. 10.1038/nrc1317, 15057285.
16. Bhalla KN. Microtubule-targeted anticancer agents and apoptosis. Oncogene 2003, 22:9075-9086. 10.1038/sj.onc.1207233, 14663486.
17. Mollinedo F, Gajate C. Microtubules, microtubule-interfering agents and apoptosis. Apoptosis 2003, 8:413-450. 10.1023/A:1025513106330, 12975575.
18. Xiao H, Verdier-Pinard P, Fernandez-Fuentes N, Burd B, Angeletti R, Fiser A, Horwitz SB, Orr GA. Insights into the mechanism of microtubule stabilization by Taxol. Proc Natl Acad Sci USA 2006, 103:10166-10173. 10.1073/pnas.0603704103, 1502429, 16801540.
19. Sakaushi S, Nishida K, Fukada T, Senda-Murata K, Oka S, Sugimoto K. Differential responses of mitotic spindle pole formation to microtubule-stabilizing agents epothilones A and B at low concentrations. Cell Cycle 2008, 7:477-483. 10.4161/cc.7.4.5313, 18235240.
20. Gigant B, Wang C, Ravelli RB, Roussi F, Steinmetz MO, Curmi PA, Sobel A, Knossow M. Structural basis for the regulation of tubulin by vinblastine. Nature 2005, 435:519-522. 10.1038/nature03566, 15917812.
21. Yang H, Ganguly A, Cabral F. Inhibition of cell migration and cell division correlates with distinct effects of microtubule inhibiting drugs. J Biol Chem 2010, 285:32242-32250. 10.1074/jbc.M110.160820, 2952225, 20696757.
22. Tavaria M, Gabriele T, Kola I, Anderson RL. A hitchhiker's guide to the human Hsp70 family. Cell Stress Chaperones 1996, 1:23-28. 10.1379/1466-1268(1996)001<0023:AHSGTT>2.3.CO;2, 313013, 9222585.
23. Morano KA. New tricks for an old dog: the evolving world of Hsp70. Ann N Y Acad Sci 2007, 1113:1-14. 10.1196/annals.1391.018, 18095388.
24. Lindstrom MS. NPM1/B23: A Multifunctional Chaperone in Ribosome Biogenesis and Chromatin Remodeling. Biochem Res Int 2011, 2011:195-209.
25. Kongtun S, Jiratchariyakul W, Kummalue T, Tan-ariya P, Kunnachak S, Frahm AW. Cytotoxic properties of root extract and fruit juice of Trichosanthes cucumerina. Planta Med 2009, 75:839-842. 10.1055/s-0029-1185455, 19288406.
26. Duangmano S, Dakeng S, Jiratchariyakul W, Suksamrarn A, Smith DR, Patmasiriwat P. Antiproliferative Effects of Cucurbitacin B in Breast Cancer Cells: Down-Regulation of the c-Myc/hTERT/Telomerase Pathway and Obstruction of the Cell Cycle. Int J Mol Sci 2010, 11:5323-5338. 10.3390/ijms11125323, 3100835, 21614210.
27. Dakeng S, Duangmano S, Jiratchariyakul W, Y UP, Bogler O, Patmasiriwat P. Inhibition of Wnt signaling by cucurbitacin B in breast cancer cells: Reduction of Wnt-associated proteins and reduced translocation of galectin-3-mediated beta-catenin to the nucleus. J Cell Biochem 2012, 113:49-60. 10.1002/jcb.23326, 21866566.
28. Haritunians T, Gueller S, Zhang L, Badr R, Yin D, Xing H, Fung MC, Koeffler HP. Cucurbitacin B induces differentiation, cell cycle arrest, and actin cytoskeletal alterations in myeloid leukemia cells. Leuk Res 2008, 32:1366-1373. 10.1016/j.leukres.2008.01.019, 18405967.
29. Bhat KM, Setaluri V. Microtubule-associated proteins as targets in cancer chemotherapy. Clin Cancer Res 2007, 13:2849-2854. 10.1158/1078-0432.CCR-06-3040, 17504982.
30. Nakazawa J, Yajima J, Usui T, Ueki M, Takatsuki A, Imoto M, Toyoshima YY, Osada H. A novel action of terpendole E on the motor activity of mitotic Kinesin Eg5. Chem Biol 2003, 10:131-137. 10.1016/S1074-5521(03)00020-6, 12618185.
31. Chan PK, Chan FY. Nucleophosmin/B23 (NPM) oligomer is a major and stable entity in HeLa cells. Biochim Biophys Acta 1995, 1262:37-42. 10.1016/0167-4781(95)00044-H, 7772597.
32. Liu WH, Yung BY. Mortalization of human promyelocytic leukemia HL-60 cells to be more susceptible to sodium butyrate-induced apoptosis and inhibition of telomerase activity by down-regulation of nucleophosmin/B23. Oncogene 1998, 17:3055-3064. 10.1038/sj.onc.1202234, 9881708.
33. Wu HL, Hsu CY, Liu WH, Yung BY. Berberine-induced apoptosis of human leukemia HL-60 cells is associated with down-regulation of nucleophosmin/B23 and telomerase activity. Int J Cancer 1999, 81:923-929. 10.1002/(SICI)1097-0215(19990611)81:6<923::AID-IJC14>3.0.CO;2-D, 10362140.
34. Wu MH, Lam CY, Yung BY. Translocation of nucleophosmin from nucleoli to nucleoplasm requires ATP. Biochem J 1995, 305(Pt 3):987-992. 1136355, 7848301.
35. Chan PK, Chan FY. A study of correlation between NPM-translocation and apoptosis in cells induced by daunomycin. Biochem Pharmacol 1999, 57:1265-1273. 10.1016/S0006-2952(99)00043-X, 10230770.
36. Chan PK. Characterization and cellular localization of nucleophosmin/B23 in HeLa cells treated with selected cytotoxic agents (studies of B23-translocation mechanism). Exp Cell Res 1992, 203:174-181. 10.1016/0014-4827(92)90053-B, 1426041.
37. Kohlhuber F, Hermeking H, Graessmann A, Eick D. Induction of apoptosis by the c-Myc helix-loop-helix/leucine zipper domain in mouse 3T3-L1 fibroblasts. J Biol Chem 1995, 270:28797-28805. 10.1074/jbc.270.48.28797, 7499403.
38. Evan GI, Wyllie AH, Gilbert CS, Littlewood TD, Land H, Brooks M, Waters CM, Penn LZ, Hancock DC. Induction of apoptosis in fibroblasts by c-myc protein. Cell 1992, 69:119-128. 10.1016/0092-8674(92)90123-T, 1555236.
39. Alexandrova N, Niklinski J, Bliskovsky V, Otterson GA, Blake M, Kaye FJ, Zajac-Kaye M. The N-terminal domain of c-Myc associates with alpha-tubulin and microtubules in vivo and in vitro. Mol Cell Biol 1995, 15:5188-5195. 230766, 7651436.
40. el Khyari S, Bourgarel V, Barra Y, Braguer D, Briand C. Pretreatment by tubulin inhibitory agents decrease C-MYC induction in human colon carcinoma cell line HT29-D4. Biochem Biophys Res Commun 1997, 231:751-754. 10.1006/bbrc.1997.6187, 9070886.
41. Zeller KI, Haggerty TJ, Barrett JF, Guo Q, Wonsey DR, Dang CV. Characterization of nucleophosmin (B23) as a Myc target by scanning chromatin immunoprecipitation. J Biol Chem 2001, 276:48285-48291.
42. Yung BY. c-Myc-mediated expression of nucleophosmin/B23 decreases during retinoic acid-induced differentiation of human leukemia HL-60 cells. FEBS Lett 2004, 578:211-216. 10.1016/j.febslet.2004.08.089, 15589822.